mynth
← DATABASE
07/2024

MASCO GROUP acquired by ARDIAN

ITALY Healthcare Services EV 500M - 1.5b EUR

Context

Ardian acquired a majority stake in Masco Group from RSBG Infrastructure (the investment arm of the RAG-Stiftung). The transaction marks a new phase of international expansion for Masco, which has grown significantly through acquisitions such as Stilmas, Olsa, and BCD Engineering. Under the new ownership structure, CEO Luca Borella retained his position and a significant minority stake. Ardian intends to leverage its global network and "Buy-and-Build" expertise to accelerate Masco's footprint in North America and Asia, while deepening its technological capabilities in the high-growth biologics and injectable drug sectors.

MASCO GROUP, which reported an EBITDA margin of in 2023, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Masco Group is a leading global provider of high-purity water systems and engineered solutions for the pharmaceutical and biotech industries. The group specializes in "clean utilities" (purified water, steam) and complex process technologies required for the manufacturing of injectable drugs, vaccines, and cell & gene therapies.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2023
2022

Similar deals in Healthcare Services

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
04/2025TRANSCARENTACCOLADEUNITED STATESHealth Tech
10/2024FullscriptRupa HealthUNITED STATESHealth Tech
06/2024PERMIRAPHARMACORDUNITED STATESHealth Tech
05/202421 INVEST / OAKLEY CAPITAL INVESTMENTSPRODUCT LIFEFRANCEHealthcare Services
10/2023MOTION EQUITY PARTNERSBANOOKFRANCECRO / Clinical Trials
09/2023PERMIRAERGOMEDUNITED KINGDOMCRO / Clinical Trials
09/2023CERBA HEALTHCARECIRION BIOPHARMA RESEARCHCANADACRO / Clinical Trials
06/2023SUPERNOVA INVEST / HEAL CAPITALGLEAMERFRANCEHealth Tech
06/2022ASTORGOPEN HEALTHUNITED STATESHealthcare Services
11/2020KERSIASOPURABELGIUMSterilization & Hygiene

REFERENCES

Valuation range: EV 500M - 1.5b EUR

Revenue range: 250M - 500M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of MASCO GROUP by ARDIAN are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: ardian